COVID-19Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience
Key words
Abbreviations used
Cited by (0)
Supported by Fondazione Cariplo, Fondazione Veronesi, Impact of COVID19 infection on patients affected by inflammatory skin diseases on immuno-suppressive therapies (COVISKIN); ID 1833073 rif. 2020-1363.
Disclosure of potential conflict of interest: P. Gisondi has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Janssen, LEO Pharma, Eli Lilly, Novartis, Pierre Fabre, Pfizer, Sandoz, and UCB. S. Piaserico has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Janssen, LEO Pharma, Eli Lilly, Merck Sharp & Dohme, Novartis, Pfizer, Sandoz, and UCB. L. Naldi has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Janssen, Eli Lilly, and Novartis. P. Dapavo has been a consultant and/or speaker for Abbvie, Amgen-, LEO Pharma, Eli Lilly, Novartis, and UCB. A. Conti has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Eli Lilly, Janssen, LEO Pharma, Novartis, and UCB. P. Malagoli has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Genzyme, Janssen, LEO Pharma, Eli Lilly, Novartis, Sanofi, UCB, and Pierre Fabre. F. Bardazzi has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Janssen, LEO Pharma, Eli Lilly, Novartis, Pfizer, Sandoz, and UCB. A. Costanzo has been a consultant and/or speaker for Abbvie, Almirall, Amgen, Janssen, LEOPharma, Eli Lilly, Novartis, Pfizer, Sandoz, and UCB. The rest of the authors declare that they have no relevant conflicts of interest.
- ∗
These authors contributed equally to this work.
- ‡
Collaborators in the studies of COVID-19 pandemic: Lidia Sacchelli, Elena Pezzolo, Francesco Messina, Claudia Lasagni, Laura Bigi, Angelo Cattaneo, Carlo Giovanni Carrera, Luisa Arancio, Simone Ribero, Giulia Rozzo, Giovanni Damiani, and Paola Facheris.